SUMO3 and ovarian carcinoma: These assays found that SENP1 mRNA was highly upregulated (Fig. 4A), while SUMO3 level was decreased in platinum-resistant ovarian cancer cells (IGROV1 CR) (Fig. 4B), suggesting a possible role of SENP1 in the regulation of platinum-resistance via SUMOylation in ovarian cancer.